Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.42 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.42 |
| ▸ | GPR3 | P46089 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8021021 | 0.87 | TUBB4A (0.44) | CYP2A6MAPTHDAC3HDAC4HDAC1 | |
| SCHEMBL4067824 | 0.86 | CYP2A6 (0.40) | CYP2A6MAPTHDAC3HDAC4HDAC1 | |
| SCHEMBL13127777 | 0.84 | MAPT (0.48) | CYP2A6MAPTHDAC3HDAC4HDAC1 | |
| SCHEMBL21572394 | 0.84 | CYP2A6 (0.45) | CYP2A6MAPTHDAC3HDAC4HDAC1 | |
| SCHEMBL4057305 | 0.82 | CYP2A6 (0.61) | CYP2A6MAPTCHRNA7SMN1; SMN2CRHBP | |
| SCHEMBL4064890 | 0.80 | POLB (0.50) | MAPTHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL4058374 | 0.79 | SIRT1 (0.54) | CYP2A6MAPTHDAC3HDAC4HDAC1 | |
| SCHEMBL13111847 | 0.79 | MAPT (0.44) | CYP2A6MAPTHDAC3HDAC4HDAC1 | |
| SCHEMBL4068277 | 0.78 | IFNAR1 (0.61) | CYP2A6MAPTPKMSMN1; SMN2CA1 | |
| SCHEMBL4071403 | 0.78 | LMNA (0.60) | SMN1; SMN2ALDH1A1TDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7951962-B2 | Condensed ring compounds formed by edge sharing between the connecting ring and each of the electron-conjugated aromatic rings, which means bonding between the two atoms; pi-electron conjugated systems; improved solvent solubility allows use in ink jet printing | SEIKO EPSON CORPORATION (JP) | 2011-05-31 | — | — | US | claimed |
| US-20080076935-A1 | ORGANIC SEMICONDUCTOR COMPOUND, ORGANIC SEMICONDUCTOR THIN FILM, ORGANIC SEMICONDUCTOR COATING LIQUID, ORGANIC THIN FILM TRANSISTOR, METHODS FOR PRODUCING BIS(BENZO[4,5] THIENO)[2,3-B:3'2'-E][1,4]DITHIIN AND BIS(BENZO [4,5]THIENO)[2,3-B:2'3'-E][1,4]DITHIIN | SEIKO EPSON CORPORATION (JP) | 2008-03-27 | — | — | US | claimed |
| US-7951962-B2 | Condensed ring compounds formed by edge sharing between the connecting ring and each of the electron-conjugated aromatic rings, which means bonding between the two atoms; pi-electron conjugated systems; improved solvent solubility allows use in ink jet printing | SEIKO EPSON CORPORATION (JP) | 2011-05-31 | — | — | US | disclosed |
| US-7951962-B2 | Condensed ring compounds formed by edge sharing between the connecting ring and each of the electron-conjugated aromatic rings, which means bonding between the two atoms; pi-electron conjugated systems; improved solvent solubility allows use in ink jet printing | SEIKO EPSON CORPORATION (JP) | 2011-05-31 | — | — | US | disclosed |
| US-7951962-B2 | Condensed ring compounds formed by edge sharing between the connecting ring and each of the electron-conjugated aromatic rings, which means bonding between the two atoms; pi-electron conjugated systems; improved solvent solubility allows use in ink jet printing | SEIKO EPSON CORPORATION (JP) | 2011-05-31 | — | — | US | disclosed |
| US-20080076935-A1 | ORGANIC SEMICONDUCTOR COMPOUND, ORGANIC SEMICONDUCTOR THIN FILM, ORGANIC SEMICONDUCTOR COATING LIQUID, ORGANIC THIN FILM TRANSISTOR, METHODS FOR PRODUCING BIS(BENZO[4,5] THIENO)[2,3-B:3'2'-E][1,4]DITHIIN AND BIS(BENZO [4,5]THIENO)[2,3-B:2'3'-E][1,4]DITHIIN | SEIKO EPSON CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| US-20080076935-A1 | ORGANIC SEMICONDUCTOR COMPOUND, ORGANIC SEMICONDUCTOR THIN FILM, ORGANIC SEMICONDUCTOR COATING LIQUID, ORGANIC THIN FILM TRANSISTOR, METHODS FOR PRODUCING BIS(BENZO[4,5] THIENO)[2,3-B:3'2'-E][1,4]DITHIIN AND BIS(BENZO [4,5]THIENO)[2,3-B:2'3'-E][1,4]DITHIIN | SEIKO EPSON CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| US-20080076935-A1 | ORGANIC SEMICONDUCTOR COMPOUND, ORGANIC SEMICONDUCTOR THIN FILM, ORGANIC SEMICONDUCTOR COATING LIQUID, ORGANIC THIN FILM TRANSISTOR, METHODS FOR PRODUCING BIS(BENZO[4,5] THIENO)[2,3-B:3'2'-E][1,4]DITHIIN AND BIS(BENZO [4,5]THIENO)[2,3-B:2'3'-E][1,4]DITHIIN | SEIKO EPSON CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080076935-A1 | ORGANIC SEMICONDUCTOR COMPOUND, ORGANIC SEMICONDUCTOR THIN FILM, ORGANIC SEMICONDUCTOR COATING LIQUID, ORGANIC THIN FILM TRANSISTOR, METHODS FOR PRODUCING BIS(BENZO[4,5] THIENO)[2,3-B:3'2'-E][1,4]DITHIIN AND BIS(BENZO [4,5]THIENO)[2,3-B:2'3'-E][1,4]DITHIIN | ESYT2, DRD4, ESR2 | CYP2A6 1632/4885MAPT 1753/4885HDAC3 3725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.